Strs Ohio Edwards Lifesciences Corp Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Strs Ohio holds 143,381 shares of EW stock, worth $9.49 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

143,381

Previous 145,809 1.67%

Holding current value

$9.49 Million

Previous $13.5 Million 29.75%

% of portfolio

0.04%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$59.7 - $93.78 $144,951 - $227,697	-2,428 Reduced 1.67%	143,381 $9.46 Million
Q2 2024 Aug 05, 2024	SELL	$84.3 - $94.31 $485,146 - $542,754	-5,755 Reduced 3.8%	145,809 $13.5 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $714,954 - $941,839	-9,856 Reduced 6.11%	151,564 $14.5 Million
Q4 2023 Jan 30, 2024	SELL	$61.71 - $77.76 $412,531 - $519,825	-6,685 Reduced 3.98%	161,420 $12.3 Million
Q3 2023 Oct 26, 2023	SELL	$69.28 - $93.38 $243,657 - $328,417	-3,517 Reduced 2.05%	168,105 $11.6 Million
Q2 2023 Jul 31, 2023	BUY	$81.41 - $94.33 $14 Million - $16.2 Million	171,622 New	171,622 $16.2 Million
Q1 2023 Aug 02, 2023	BUY	$74.26 - $84.51 $1.13 Million - $1.28 Million	15,196 Added 8.85%	186,818 $15.5 Million
Q4 2022 Jan 26, 2023	SELL	$68.3 - $87.44 $2.89 Million - $3.71 Million	-42,385 Reduced 17.24%	203,417 $15.2 Million
Q3 2022 Oct 27, 2022	SELL	$82.37 - $107.29 $156,338 - $203,636	-1,898 Reduced 0.77%	245,802 $20.3 Million
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $16.9 Million - $25.1 Million	-195,357 Reduced 44.09%	247,700 $23.6 Million
Q1 2022 Apr 21, 2022	BUY	$101.96 - $128.34 $267,746 - $337,020	2,626 Added 0.6%	443,057 $52.2 Million
Q4 2021 Jan 24, 2022	BUY	$106.37 - $130.68 $1.8 Million - $2.21 Million	16,891 Added 3.99%	440,431 $57.1 Million
Q3 2021 Oct 22, 2021	SELL	$102.91 - $122.75 $7.79 Million - $9.3 Million	-75,733 Reduced 15.17%	423,540 $47.9 Million
Q2 2021 Jul 26, 2021	SELL	$83.84 - $104.76 $3.09 Million - $3.87 Million	-36,898 Reduced 6.88%	499,273 $51.7 Million
Q1 2021 Apr 23, 2021	SELL	$78.68 - $90.67 $20.5 Million - $23.6 Million	-260,537 Reduced 32.7%	536,171 $44.8 Million
Q4 2020 Jan 25, 2021	SELL	$71.69 - $91.23 $2.52 Million - $3.2 Million	-35,122 Reduced 4.22%	796,708 $72.7 Million
Q3 2020 Dec 14, 2020	SELL	$67.19 - $87.44 $11.5 Million - $14.9 Million	-170,726 Reduced 17.03%	831,830 $66.4 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $36.8 Million - $49.2 Million	639,021 Added 175.78%	1,002,556 $69.3 Million
Q1 2020 Apr 23, 2020	BUY	$52.41 - $81.0 $3.19 Million - $4.94 Million	60,953 Added 20.14%	363,535 $68.6 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $1.24 Million - $1.42 Million	-17,251 Reduced 5.39%	302,582 $70.6 Million
Q3 2019 Oct 21, 2019	SELL	$61.55 - $75.43 $957,656 - $1.17 Million	-15,559 Reduced 4.64%	319,833 $70.3 Million
Q2 2019 Jul 25, 2019	BUY	$55.74 - $64.41 $3.9 Million - $4.51 Million	69,965 Added 26.36%	335,392 $62 Million
Q1 2019 Apr 19, 2019	SELL	$47.89 - $64.05 $1,101 - $1,473	-23 Reduced 0.01%	265,427 $50.8 Million
Q4 2018 Jan 23, 2019	SELL	$46.41 - $56.94 $91,845 - $112,684	-1,979 Reduced 0.74%	265,450 $40.7 Million
Q3 2018 Oct 19, 2018	SELL	$45.7 - $58.03 $701,403 - $890,644	-15,348 Reduced 5.43%	267,429 $46.6 Million
Q2 2018 Aug 06, 2018	BUY	$42.45 - $51.3 $51,958 - $62,791	1,224 Added 0.43%	282,777 $41.2 Million
Q1 2018 Apr 20, 2018	SELL	$37.19 - $47.45 $142,177 - $181,401	-3,823 Reduced 1.34%	281,553 $39.3 Million
Q4 2017 Jan 23, 2018	SELL	$33.79 - $39.39 $277,078 - $322,998	-8,200 Reduced 2.79%	285,376 $32.2 Million
Q3 2017 Oct 23, 2017	BUY	$36.29 - $38.83 $10.7 Million - $11.4 Million	293,576	293,576 $32.1 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

6.35M

Put Options Held

2.82M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account